Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Participants must have specific stages of disease, known as Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stages IIB, IIC, III or IV
Organ functions (blood, renal, liver, cardiac) must meet specific requirements.
Participants who could become pregnant must take care not to become pregnant during the study participation and for 6 months after study discontinuation
Participants must give written consent for study participation.
You may not be if
Participants received any experimental drug within the last 30 days.
Participants received any prior chemotherapy or other drug therapy for the current disease.
Participants receive any other treatment for the cancer during study participation.
Participants are unable to discontinue concurrent administration of carbamazepine, phenobarbital, or phenytoin.
Participants are pregnant, breast feeding, or not using adequate contraceptive methods to prevent pregnancy.
Clareo Health | Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")
